排序方式:
    總頁 1 
      Go

    1.CYP2C19 Loss-of-function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 Diabetes

    Wang, K, Yang, AM, S     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2021, Volume 111, Issue 2, Pages 461-469

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2022影響因子:  6.7  发表年影響因子:  7.051 

    2.ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin

    Tomlinson, B, Hu, M,     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2010, Volume 87, Issue 5, Pages 558-562

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 110  2022影響因子:  6.7  发表年影響因子:  6.378 

    3.MDR1 haplotype dependent effect on cloxacillin pharmacokinetics in human subjects.

    Yin, OQ, Tomlinson,     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2008, Volume 83, Pages S65-S66

    收錄情况: WOS

    2022影響因子:  6.7  发表年影響因子:  7.586 

    4.No association between CYP3A5 genotype and blood pressure in healthy Chinese subjects.

    Yin, QQ, Tomlinson,     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2006, Volume 79, Issue 2, Pages P11-P11

    收錄情况: WOS

    2022影響因子:  6.7  发表年影響因子:  8.066 

    5.CYP3A5 but not CYP2D6 polymorphism affects dextropropoxyphene disposition in human subjects.

    Chow, MS, Yin, OQ, T     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2006, Volume 79, Issue 2, Pages P50-P50

    收錄情况: WOS

    2022影響因子:  6.7  发表年影響因子:  8.066 

    6.Effects of combined CYP2C9 and 2C19 polymorphism on the pharmacokinetics of glibenclamide in Chinese subjects.

    Yin, OQ, Tomlinson,     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2005, Volume 77, Issue 2, Pages P23-P23

    收錄情况: WOS

    2022影響因子:  6.7  发表年影響因子:  7.526 

    7.A five-probe drug cocktail for phenotyping of CYP isozymes with "high-throughput" LC-MS method.

    Yin, OQ, Tomlinson,     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2005, Volume 77, Issue 2, Pages P35-P35

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  6.7  发表年影響因子:  7.526 

    8.CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects

    Yin, OQP, Tomlinson,     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2005, Volume 78, Issue 4, Pages 370-377

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 52  2022影響因子:  6.7  发表年影響因子:  7.526 

    9.The effect of CYP2D6 genotype on the pharmacokinetics of lovastatin in Chinese subjects.

    Yin, OQ, Chang, Q, T     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2004, Volume 75, Issue 2, Pages P18-P18

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  6.7  发表年影響因子:  6.825 

    10.Reliability of a single omeprazole/hydroxyomeprazole plasma concentration ratio for CYP2C19 phenotype determination in Chinese subjects.

    Yin, OQ, Tomlinson,     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2003, Volume 73, Issue 2, Pages P43-P43

    收錄情况: WOS

    2022影響因子:  6.7  发表年影響因子:  6.141 

    11.Prediction and mechanism of herb-drug interaction: Effect of ginkgo biloba on omeprazole in Chinese subjects.

    Yin, OQ, Tomlinson,     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2003, Volume 73, Issue 2, Pages P94-P94

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  6.7  发表年影響因子:  6.141 

    12.A "high-throughput" cocktail method for screening the effect of herbal product on liver isozyme activities: Experience with Ginkgo biloba.

    Sun, H, Zuo, Z, Yin,     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2002, Volume 71, Issue 2, Pages P100-P100

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  6.7  发表年影響因子:  5.336 

    13.Comparison of two pharmacokinetic models to describe the double-peak absorption profiles of ranitidine.

    Chow, MSS, Yin, QP,     More...

    CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2001, Volume 69, Issue 2, Pages P23-P23

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  6.7  发表年影響因子:  5.061 

    14.Comparison of two pharmacokinetic models to describe the double-peak absorption profiles of ranitidine

    Chow, Moses Sing Sum     More...

    Clinical Pharmacology and Therapeutics[0009-9236], Published 2001, Volume 69, Issue 2,

    收錄情况: SCOPUS

    2022影響因子:  6.7  发表年影響因子:  5.061 

    顯示      條  合計   14   條
      總頁 1 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫